Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2019: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2018: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Monocytes in human peripheral blood are heterogeneous. Differential expression of CD14 and CD16 enables monocytes to be divided into two subsets: CD14+CD16- monocytes and CD14+CD16+ monocytes, called as “inflammatory” and “pro-inflammatory”. We proved that increasing of pro-inflammatory monocyte could predict future coronary artery event. In patients with acute myocardial infarction, both inflammatory monocyte and interleukin-34 increased and related with each other. In addition, those increasing were associated with myocardial remodeling and major adverse cardiovascular events.
|